Peter Marschel, MS, MBA

Peter Marschel co-founded Decoy Therapeutics in 2020 and serves as Chief Business Officer, leading business development and partnering. He previously co-founded PercepTx, a targeted cancer immunotherapy company, and served as its Chief Financial Officer. Earlier in his career he held business development, analytics and commercial roles at Merck, Vertex Pharmaceuticals and Takeda, including leading market analytics for the cystic fibrosis franchise at Vertex.